# COHERUS ONCOLOGY INC (CHRS)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/CHRS/

- Reporting holders: 3
- Reported value: $9.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $4.9K | 4,063 | 0.0% | 4 |
| [CoreCap Advisors, LLC](https://holderbook.com/funds/1902501-corecap-advisors-llc/) | $3.5K | 2,924 | 0.0% | 3 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $559 | 462 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $9.0K |
| Q2 2026 | 147 | $104.6M |
| Q1 2026 | 157 | $121.3M |
| Q4 2025 | 128 | $82.0M |
| Q3 2025 | 114 | $86.0M |
| Q2 2025 | 111 | $40.8M |
| Q1 2025 | 116 | $50.2M |
| Q4 2024 | 127 | $98.1M |
| Q3 2024 | 127 | $80.5M |
| Q2 2024 | 135 | $144.0M |
| Q1 2024 | 136 | $212.9M |
| Q4 2023 | 157 | $284.4M |